Boothe Investment Group, Inc. Gsk PLC Transaction History

Boothe Investment Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$42.05 - $47.77 $41,671 - $47,340	-991 Reduced 4.05%	23,448 $1.03 Million
Q1 2022 May 11, 2022	BUY	$40.23 - $47.74 $87,419 - $103,739	2,173 Added 9.76%	24,439 $1.07 Million
Q4 2021 Jan 25, 2022	BUY	$38.88 - $45.31 $17,496 - $20,389	450 Added 2.06%	22,266 $982,000
Q3 2021 Oct 06, 2021	BUY	$38.79 - $43.16 $14,817 - $16,487	382 Added 1.78%	21,816 $832,000
Q2 2021 Jul 28, 2021	BUY	$36.52 - $41.46 $59,345 - $67,372	1,625 Added 8.2%	21,434 $861,000
Q1 2021 Apr 06, 2021	BUY	$34.27 - $40.01 $678,854 - $792,558	19,809 New	19,809 $707,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Boothe Investment Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Boothe Investment Group, Inc. with notifications on news.